CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Cardiac Shock Care Centers: JACC Review Topic of the Week Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I Predicting Major Adverse Events in Patients With Acute Myocardial Infarction Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 Percutaneous Support Devices for Percutaneous Coronary Intervention Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review

Review Article2020 Jul 21;142(3):275-291.

JOURNAL:Circulation. Article Link

Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress

LJ He, NB Nguyen, R Ardehali et al. Keywords: myocardial infarction; myocytes, cardiac; stem cells

Full Text PDF